Cite
Efficacy of a Novel Palivizumab Prophylaxis Protocol for Respiratory Syncytial Virus Infection in Congenital Heart Disease: A Multicenter Study
MLA
Yu Chuan Hua, et al. “Efficacy of a Novel Palivizumab Prophylaxis Protocol for Respiratory Syncytial Virus Infection in Congenital Heart Disease: A Multicenter Study.” The Journal of Pediatrics, vol. 195, June 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2c005a271b5599bbf880925be72deb35&authtype=sso&custid=ns315887.
APA
Yu Chuan Hua, Mei-Hwan Wu, Jieh Neng Wang, Yun Ching Fu, Chun-Wei Lu, Shuenn-Nan Chiu, Chun-An Chen, Hung Tao Chung, Jing-Ming Wu, Ling Yin Chang, Jou-Kou Wang, & Ming-Tai Lin. (2017). Efficacy of a Novel Palivizumab Prophylaxis Protocol for Respiratory Syncytial Virus Infection in Congenital Heart Disease: A Multicenter Study. The Journal of Pediatrics, 195.
Chicago
Yu Chuan Hua, Mei-Hwan Wu, Jieh Neng Wang, Yun Ching Fu, Chun-Wei Lu, Shuenn-Nan Chiu, Chun-An Chen, et al. 2017. “Efficacy of a Novel Palivizumab Prophylaxis Protocol for Respiratory Syncytial Virus Infection in Congenital Heart Disease: A Multicenter Study.” The Journal of Pediatrics 195 (June). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2c005a271b5599bbf880925be72deb35&authtype=sso&custid=ns315887.